[Adhesion molecules and glomerulonephritis. Towards novel therapeutic strategies].
Arrizabalaga Clemente
Pilar
P
Servicio de Nefrología. Hospital Clínic. Institut d'Investigació Biomèdica August Pi i Sunyer. Barcelona. España. parrizabala@senefro.org
D000208:Acute Disease; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015815:Cell Adhesion Molecules / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology; D002465:Cell Movement; D002478:Cells, Cultured; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D005921:Glomerulonephritis / Q000097:blood / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007136:Immunoglobulins / Q000502:physiology; D016023:Integrins / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood / Q000378:metabolism / Q000502:physiology; D008181:Lupus Nephritis / Q000097:blood / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D051379:Mice; D018345:Mice, Knockout; D011379:Prognosis; D011817:Rabbits; D051381:Rats; D011921:Rats, Inbred WKY; D019087:Selectins / Q000378:metabolism / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood / Q000378:metabolism / Q000502:physiology
D000911:Antibodies, Monoclonal; D015815:Cell Adhesion Molecules; D007136:Immunoglobulins; D016023:Integrins; D019087:Selectins; D014409:Tumor Necrosis Factor-alpha; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1